S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/RTW Investments/Q1 2025

RTW Investments

Period: Q1 2025 Β· Filed: 2025-05-15
View on SEC EDGAR β†—
AUM
$6.54B
Total portfolio value
Positions
68
Reported securities
Top Holding
MDGL
10.1% $660.4M
QoQ Changes
+8 / -8
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2025-05-15) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
MDGLMADRIGAL PHARMACEUTICALS INC$660.4M10.10%$331.23$528.10+59.4%
10.1%
ARGXARGENX SE$398.6M6.10%$591.86$939.68+58.8%
6.1%
PTCTPTC THERAPEUTICS INC$381.3M5.83%$50.96$83.31+63.5%
5.8%
NTRANATERA INC$366.8M5.61%$141.41$279.32+97.5%
5.6%
AXSMAXSOME THERAPEUTICS INC$340.9M5.21%$116.63$244.31+109.5%
5.2%
AKROAKERO THERAPEUTICS INC$300.3M4.59%β€”β€”
4.6%
PTGXPROTAGONIST THERAPEUTICS INC$276.6M4.23%$48.36$131.62+172.2%
4.2%
RNAMAVIDITY BIOSCIENCES INC$258.2M3.95%β€”β€”
4.0%
PENPENUMBRA INC$230.7M3.53%$267.41$318.57+19.1%
3.5%
INSMINSMED INC$230.0M3.52%$76.29$111.60+46.3%
3.5%
ALKSALKERMES PLC$227.3M3.48%$33.02$54.58+65.3%
3.5%
SYKSTRYKER CORPORATION$219.7M3.36%$367.71$326.54-11.2%
3.4%
VRNAVERONA PHARMA PLC$180.9M2.77%β€”β€”
2.8%
MRUSMERUS N V$175.5M2.68%β€”β€”
2.7%
TARSTARSUS PHARMACEUTICALS INC$170.3M2.61%$51.37$65.44+27.4%
2.6%
IMCRIMMUNOCORE HLDGS PLC$144.5M2.21%$29.67$32.50+9.5%
2.2%
ACADACADIA PHARMACEUTICALS INC$141.8M2.17%$16.61$25.97+56.4%
2.2%
RCKTROCKET PHARMACEUTICALS INC$118.0M1.80%$6.67$3.84-42.4%
1.8%
RDNTRADNET INC$115.2M1.76%$49.72$68.75+38.3%
1.8%
MASIMASIMO CORP$113.8M1.74%$166.60β€”
1.7%
ZLABZAI LAB LTD$113.4M1.73%$36.14$19.12-47.1%
1.7%
CYTKCYTOKINETICS INC$109.4M1.67%$40.19$86.49+115.2%
1.7%
ESTAESTABLISHMENT LABS HLDGS INC$105.4M1.61%$40.81$89.25+118.7%
1.6%
APGEAPOGEE THERAPEUTICS INC$101.3M1.55%$37.36$132.91+255.8%
1.6%
ISRGINTUITIVE SURGICAL INC$100.3M1.53%$495.27$426.01-14.0%
1.5%
GMEDGLOBUS MED INC$82.3M1.26%$73.20$80.12+9.4%
1.3%
RAREULTRAGENYX PHARMACEUTICAL IN$61.8M0.95%$36.21$33.47-7.6%
0.9%
GHRSGH RESEARCH PLC$60.7M0.93%$11.03$27.01+144.9%
0.9%
SYRESPYRE THERAPEUTICS INC$58.4M0.89%$16.14$86.63+436.7%
0.9%
QUREUNIQURE NV$45.2M0.69%$10.60$41.81+294.4%
0.7%

Quarter-on-Quarter Activity

Q1 2025 vs. Q4 2024

New Positions (8)

TickerIssuerNotionalSince Filing
ISRGINTUITIVE SURGICAL INC$100.3M-14.0%
GEHCGE HEALTHCARE TECHNOLOGIES I$42.0M
BBNXBETA BIONICS INC$40.4M
VSTMVERASTEM INC$25.6M
TEMTEMPUS AI INC$19.3M
GKOSGLAUKOS CORP$18.7M
DGXQUEST DIAGNOSTICS INC$16.8M
BEAMBEAM THERAPEUTICS INC$8.6M

Exited Positions (8)

TickerIssuerNotional
BRKRBRUKER CORP$145.4M
ROIVROIVANT SCIENCES LTD$17.2M
SAGESAGE THERAPEUTICS INC$16.3M
TRMLTOURMALINE BIO INC$14.9M
DNTHDIANTHUS THERAPEUTICS INC$14.5M
IMVTIMMUNOVANT INC$13.1M
PEPGPEPGEN INC$12.1M
IDYAIDEAYA BIOSCIENCES INC$5.1M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
QUREUNIQURE NV$29.3M+372.0%+294.4%
TSHATAYSHA GENE THERAPIES INC$11.1M+116.6%
CMPSCOMPASS PATHWAYS PLC$4.1M+78.7%
GHRSGH RESEARCH PLC$37.4M+65.3%+144.9%
VRNAVERONA PHARMA PLC$96.3M+56.4%
ZLABZAI LAB LTD$47.6M+25.0%-47.1%
RDNTRADNET INC$-22.9M+17.1%+38.3%
GMEDGLOBUS MED INC$2.0M+15.7%+9.4%

Trimmed (7)

TickerIssuerNotionalShares Ξ”Since Filing
ETNB89BIO INC$-44.2M-73.7%
DYNDYNE THERAPEUTICS INC$-105.3M-67.6%
AXSMAXSOME THERAPEUTICS INC$-1.9M-27.9%+109.5%
RAREULTRAGENYX PHARMACEUTICAL IN$-21.0M-13.2%-7.6%
ALKSALKERMES PLC$10.0M-8.9%+65.3%
ACADACADIA PHARMACEUTICALS INC$-17.9M-1.9%+56.4%
NGNENEUROGENE INC$-15.1M-0.1%
← Back to Hedge Funds